The Durvalumab Biosimilar Anti-PD-L1 Antibody is a cutting-edge therapeutic antibody designed for research and potentially clinical applications. This biosimilar antibody targets the PD-L1 protein, a critical immune checkpoint molecule that helps cancer cells evade the immune system. By blocking PD-L1, Durvalumab enhances the immune response against cancer cells, making it a promising tool in cancer immunotherapy.This antibody is highly specific for PD-L1 and has been validated for use in various experimental settings, including flow cytometry, immunohistochemistry, and functional assays.
Its high affinity and potency make it an excellent choice for studying PD-L1 expression and function in cancer cells and tumor microenvironments.Overall, the Durvalumab Biosimilar Anti-PD-L1 Antibody is a valuable tool for researchers studying cancer immunology and exploring new strategies for cancer therapy. Its potential as a therapeutic agent in the treatment of various cancer types makes it a promising candidate for further development and investigation.
Product Name:
Durvalumab (Anti-PDL1) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0133
Target:
PDL1
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MEDI4736
Description:
Anti-PDL1 (durvalumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
